HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2-Fluoroestradiol. Separation of estrogenicity from carcinogenicity.

Abstract
Estrogenic and carcinogenic activity are shown to be separable properties. 2-Fluoroestradiol, a modified estrogen, did not induce renal clear-cell carcinoma in male Syrian hamsters despite its estrogenic potency, which is comparable to that of estradiol. 4-Fluoroestradiol, also a potent estrogen, did induce renal clear-cell carcinoma in this animal model, but more slowly than estradiol. 2,4-Dideuterioestradiol was found to be as estrogenic and also as carcinogenic as estradiol itself.
AuthorsJ G Liehr
JournalMolecular pharmacology (Mol Pharmacol) Vol. 23 Issue 2 Pg. 278-81 (Mar 1983) ISSN: 0026-895X [Print] United States
PMID6682170 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • 2-fluoroestradiol
  • Estradiol
Topics
  • Adenocarcinoma (chemically induced)
  • Animals
  • Cricetinae
  • Estradiol (analogs & derivatives, pharmacology)
  • Female
  • Kidney Neoplasms (chemically induced)
  • Male
  • Mesocricetus
  • Organ Size (drug effects)
  • Rats
  • Rats, Inbred Strains
  • Testis (drug effects)
  • Uterus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: